Rockefeller Capital Management
BSTC

Rockefeller Capital Management’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Rockefeller Capital Management’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-105
Closed -$5K – 3092
2020
Q3 		$5K Buy
105
+38
+57% +$2.35K ﹤0.01% 2255
2020
Q2 		$4K Sell
67
-41
-38% -$2.37K ﹤0.01% 2195
2020
Q1 		$6K Buy
+108
New +$6.16K ﹤0.01% 1927

Other funds holding BSTC

UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Rockefeller Capital Management's BSTC Position: Q4 2020 in Review

Rockefeller Capital Management sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 105 shares — an estimated $5K sold.

Rockefeller Capital Management first reported a position in BSTC in Q1 2020 and held it in 3 quarters. The position peaked at $6K in Q1 2020. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.

  • Rockefeller Capital Management reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
  • Rockefeller Capital Management sold 105 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $5K.
  • Rockefeller Capital Management first reported a position in BioSpecifics Technologies Corp. in Q1 2020 and held it in 3 quarters.
  • Rockefeller Capital Management's BioSpecifics Technologies Corp. position peaked at $6K in Q1 2020.
  • 1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.

Based on Rockefeller Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.